Utilizing the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated with Adjuvant Radiotherapy

BACKGROUND: Variability exists in the adjuvant treatment for endometrial cancer (EC) based on surgical pathology and institutional preference. The radiosensitivity index (RSI) is a previously validated multigene expression index that estimates tumor radiosensitivity. We evaluate RSI as a genomic pre...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Radiat Oncol Biol Phys
Autors principals: Mohammadi, Homan, Prince, Austin, Figura, Nicholas B., Peacock, Jeffrey S., Fernandez, Daniel C., Montejo, Michael E., Chon, Hye Sook, Wenham, Robert M., Eschrich, Steven A., Torres-Roca, Javier F., Ahmed, Kamran A.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7050205/
https://ncbi.nlm.nih.gov/pubmed/31759077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.11.013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars